UKBouldering.com
the shizzle => news => Topic started by: Snoops on May 05, 2022, 01:29:18 pm
-
https://www.theguardian.com/science/2022/may/05/dupuytrens-disease-hand-finger-bending-treatment-clinical-trial-oxford-university (https://www.theguardian.com/science/2022/may/05/dupuytrens-disease-hand-finger-bending-treatment-clinical-trial-oxford-university)
-
Interesting. Wonder what is defined as "early". I've had nodules for years, but they haven't really developed.
-
Seems.. 'The ideal treatment would be effective during the early nodular stages of the disease to prevent the development of cords and progression to finger contractures'
It's a anti-TNF drug, and 3 x a year would not cause many side effects, most patients on it for Rheumatoid etc are 2/4 weekly
Here is the link to the paper:
https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(22)00093-5/fulltext (https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(22)00093-5/fulltext)
-
what's it got against The North Face? :)
-
I've got a load of (out of date/fridge) adalimumab under my bed. Sounds interesting though!